A leadless dual-chamber pacemaker with bidirectional wireless communication turned in very promising short-term results in patients with standard indications for dual-chamber pacing, according to the Aveir DR i2i Study.

Coronary anatomy and physiology both predicted early cardiac allograft vasculopathy (CAV) progression, according to a study that strengthens the case for advanced multimodal testing to improve early detection of a major contributor to allograft failure.

DiA Imaging Analysis, an Israel-based healthcare technology company, has gained U.S. Food and Drug Administration (FDA) clearance for LVivo IQS, a new software solution designed to help users acquire high-quality echocardiography images, regardless of their experience.

The vast majority of 500 artificial intelligence (AI) algorithms now cleared for clinical use in the U.S. are for radiology and cardiology. For this reason, cardiologists and radiologists need to learn how these technologies work and realise the clinical use of AI is no longer science fiction.

The ACC/AHA 2021 Chest Pain Assessment Guidelines boosted coronary computed tomography angiography (CCTA) to a Class 1A level of clinical evidence and helped significantly boost interest in building or expanding cardiac CT programs in the past year. While Cardiac CTA does have a large amount of clinical study support, there are some gaps remaining yet...

Congratulations Klaire Garnica, Head of CT at St Vincent’s Hospital, Sydney and her talented team for reaching 10,000 cardiac scans TODAY. A milestone for everyone involved, especially all the patients who have undergone exams on their personal journeys to better health.